The impact of overlap of drug-eluting stents on clinical and angiographic outcomes is controversial. Individuals with long coronary lesions requiring implantation of multiple stents are an important patient subgroup for whom careful evaluation and decision-making with optimal stent deployment is needed to ensure the best possible short-term and long-term results.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Babapulle, M. N., Joseph, L., Bélisle, P., Brophy, J. M. & Eisenberg, M. J. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364, 583–591 (2004).
Räber, L. et al. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J. Am. Coll. Cardiol. 55, 1178–1188 (2010).
Windecker, S. et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N. Engl. J. Med. 353, 653–662 (2005).
Gerber, R. T. et al. Defining a new standard for IVUS optimized drug eluting stent implantation: the PRAVIO study. Catheter Cardiovasc. Interv. 74, 348–356 (2009).
Romagnoli, E., Sangiorgi, G. M., Cosgrave, J., Guillet, E. & Colombo, A. Drug-eluting stenting: the case for post-dilation. JACC Cardiovasc. Interv. 1, 22–31 (2008).
Finn, A. V. et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 112, 270–278 (2005).
Sharp, A. S. et al. Long-term follow-up on a large cohort of “full-metal jacket” percutaneous coronary intervention procedures. Circ. Cardiovasc. Interv. 2, 416–422 (2009).
Aoki, J. et al. “Full metal jacket” (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. Am. Heart J. 1 50, 994–999 (2005).
Kereiakes, D. J. et al. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J. Am. Coll. Cardiol. 48, 21–31 (2006).
Tsagalou, E. et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J. Am. Coll. Cardiol. 45, 1570–1573 (2005).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Colombo, A., Al-Lamee, R. Does stent overlap make a difference to clinical outcome?. Nat Rev Cardiol 7, 362–364 (2010). https://doi.org/10.1038/nrcardio.2010.72
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2010.72
